Market Closed -
Nasdaq
01:30:00 27/04/2024 am IST
|
5-day change
|
1st Jan Change
|
1.53
USD
|
+0.66%
|
|
+11.68%
|
+73.86%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
14.34
|
37.11
|
202.6
|
66.92
|
110.3
|
191.7
|
-
|
-
|
Enterprise Value (EV)
1 |
14.34
|
37.11
|
202.6
|
66.92
|
110.3
|
191.7
|
191.7
|
191.7
|
P/E ratio
|
-0.77
x
|
-0.48
x
|
-8.89
x
|
-2.52
x
|
-3.67
x
|
-5.72
x
|
-5.16
x
|
6.65
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
2.05
x
|
EV / Revenue
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
2.05
x
|
EV / EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EV / FCF
|
-
|
-
|
-
|
-
|
-5.26
x
|
-7.99
x
|
-5.33
x
|
-27.4
x
|
FCF Yield
|
-
|
-
|
-
|
-
|
-19%
|
-12.5%
|
-18.8%
|
-3.65%
|
Price to Book
|
-
|
1.66
x
|
1.47
x
|
0.57
x
|
1.22
x
|
3.06
x
|
-
|
-
|
Nbr of stocks (in thousands)
|
9,131
|
39,068
|
1,26,624
|
1,26,624
|
1,25,304
|
1,25,304
|
-
|
-
|
Reference price
2 |
1.570
|
0.9500
|
1.600
|
0.5285
|
0.8800
|
1.530
|
1.530
|
1.530
|
Announcement Date
|
26/03/20
|
31/03/21
|
28/02/22
|
22/03/23
|
01/04/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
93.69
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-17.27
|
-14.61
|
-20.52
|
-27.69
|
-31.38
|
-36.58
|
-42.33
|
21.06
|
Operating Margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
22.47%
|
Earnings before Tax (EBT)
1 |
-17.24
|
-17.83
|
-20.61
|
-26.96
|
-30.09
|
-35.34
|
-41.73
|
21.59
|
Net income
1 |
-17.24
|
-17.83
|
-20.61
|
-26.96
|
-30.09
|
-35.34
|
-41.73
|
17.86
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
19.06%
|
EPS
2 |
-2.030
|
-1.970
|
-0.1800
|
-0.2100
|
-0.2400
|
-0.2675
|
-0.2967
|
0.2300
|
Free Cash Flow
1 |
-
|
-
|
-
|
-
|
-20.96
|
-24
|
-36
|
-7
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-7.47%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
26/03/20
|
31/03/21
|
28/02/22
|
22/03/23
|
01/04/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Net sales
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-5.159
|
-4.828
|
-4.747
|
-6.595
|
-8.205
|
-8.138
|
-7.098
|
-7.793
|
-7.468
|
-9.019
|
-8.5
|
-8.8
|
-9.1
|
-9.467
|
Operating Margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
1 |
-5.197
|
-4.832
|
-4.786
|
-6.672
|
-8.011
|
-7.491
|
-6.281
|
-9.83
|
-6.229
|
-7.754
|
-8.133
|
-8.467
|
-8.8
|
-9.233
|
Net income
1 |
-5.197
|
-4.832
|
-4.786
|
-6.672
|
-8.011
|
-7.491
|
-6.281
|
-9.83
|
-6.229
|
-7.754
|
-8.133
|
-8.467
|
-8.8
|
-9.233
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
2 |
-0.0400
|
-0.0400
|
-0.0400
|
-0.0500
|
-0.0600
|
-0.0600
|
-0.0500
|
-0.0800
|
-0.0500
|
-0.0600
|
-0.0633
|
-0.0633
|
-0.0667
|
-0.0700
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
15/11/21
|
28/02/22
|
09/05/22
|
08/08/22
|
07/11/22
|
22/03/23
|
15/05/23
|
14/08/23
|
13/11/23
|
01/04/24
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-
|
-
|
-
|
-21
|
-24
|
-36
|
-7
|
ROE (net income / shareholders' equity)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
-
|
0.5700
|
1.090
|
0.9300
|
0.7200
|
0.5000
|
-
|
-
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
-
|
0.01
|
0.01
|
-
|
0.01
|
0.5
|
0.5
|
0.9
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
0.96%
|
Announcement Date
|
26/03/20
|
31/03/21
|
28/02/22
|
22/03/23
|
01/04/24
|
-
|
-
|
-
|
Last Close Price
1.53
USD Average target price
4.583
USD Spread / Average Target +199.56% Consensus |
1st Jan change
|
Capi.
|
---|
| +73.86% | 192M | | +1.51% | 42.75B | | +47.81% | 41.61B | | +8.57% | 41.34B | | -12.36% | 26.59B | | +8.92% | 25.49B | | -25.13% | 18.12B | | +29.17% | 12.24B | | -3.12% | 11.76B | | +6.35% | 11B |
Other Biotechnology & Medical Research
|